Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Comparison of probabilistic tractography and tract-based spatial statistics for assessing optic radiation damage in patients with autoimmune inflammatory disorders of the central nervous system.

Kuchling J, Backner Y, Oertel FC, Raz N, Bellmann-Strobl J, Ruprecht K, Paul F, Levin N, Brandt AU, Scheel M.

Neuroimage Clin. 2018 May 8;19:538-550. doi: 10.1016/j.nicl.2018.05.004. eCollection 2018.

2.

Retinal ganglion cell loss in neuromyelitis optica: a longitudinal study.

Oertel FC, Havla J, Roca-Fernández A, Lizak N, Zimmermann H, Motamedi S, Borisow N, White OB, Bellmann-Strobl J, Albrecht P, Ruprecht K, Jarius S, Palace J, Leite MI, Kuempfel T, Paul F, Brandt AU.

J Neurol Neurosurg Psychiatry. 2018 Jun 19. pii: jnnp-2018-318382. doi: 10.1136/jnnp-2018-318382. [Epub ahead of print]

PMID:
29921610
3.

Optical coherence tomography in neuromyelitis optica spectrum disorders: potential advantages for individualized monitoring of progression and therapy.

Oertel FC, Zimmermann H, Paul F, Brandt AU.

EPMA J. 2017 Dec 22;9(1):21-33. doi: 10.1007/s13167-017-0123-5. eCollection 2018 Mar. Review.

4.

Retinal optical coherence tomography shows optic disc changes in low intracranial pressure headaches: a case report.

Oertel FC, Bosello F, Petzold A.

Acta Neurol Belg. 2018 Mar;118(1):131-133. doi: 10.1007/s13760-017-0878-4. Epub 2018 Jan 3. No abstract available.

PMID:
29299774
5.

Association of Visual Impairment in Neuromyelitis Optica Spectrum Disorder With Visual Network Reorganization.

Finke C, Zimmermann H, Pache F, Oertel FC, Chavarro VS, Kramarenko Y, Bellmann-Strobl J, Ruprecht K, Brandt AU, Paul F.

JAMA Neurol. 2018 Mar 1;75(3):296-303. doi: 10.1001/jamaneurol.2017.3890.

PMID:
29297041
6.

[Optical coherence tomography in neuromyelitis optica spectrum disorders].

Oertel FC, Zimmermann H, Brandt AU, Paul F.

Nervenarzt. 2017 Dec;88(12):1411-1420. doi: 10.1007/s00115-017-0444-6. Review. German.

PMID:
29119196
7.

CuBe: parametric modeling of 3D foveal shape using cubic Bézier.

Yadav SK, Motamedi S, Oberwahrenbrock T, Oertel FC, Polthier K, Paul F, Kadas EM, Brandt AU.

Biomed Opt Express. 2017 Aug 22;8(9):4181-4199. doi: 10.1364/BOE.8.004181. eCollection 2017 Sep 1.

8.

Contribution of blood vessels to retinal nerve fiber layer thickness in NMOSD.

Oertel FC, Zimmermann H, Mikolajczak J, Weinhold M, Kadas EM, Oberwahrenbrock T, Pache F, Bellmann-Strobl J, Ruprecht K, Paul F, Brandt AU.

Neurol Neuroimmunol Neuroinflamm. 2017 Apr 18;4(3):e338. doi: 10.1212/NXI.0000000000000338. eCollection 2017 May. No abstract available.

9.

Microstructural visual system changes in AQP4-antibody-seropositive NMOSD.

Oertel FC, Kuchling J, Zimmermann H, Chien C, Schmidt F, Knier B, Bellmann-Strobl J, Korn T, Scheel M, Klistorner A, Ruprecht K, Paul F, Brandt AU.

Neurol Neuroimmunol Neuroinflamm. 2017 Feb 22;4(3):e334. doi: 10.1212/NXI.0000000000000334. eCollection 2017 May.

10.

Severe structural and functional visual system damage leads to profound loss of vision-related quality of life in patients with neuromyelitis optica spectrum disorders.

Schmidt F, Zimmermann H, Mikolajczak J, Oertel FC, Pache F, Weinhold M, Schinzel J, Bellmann-Strobl J, Ruprecht K, Paul F, Brandt AU.

Mult Scler Relat Disord. 2017 Jan;11:45-50. doi: 10.1016/j.msard.2016.11.008. Epub 2016 Nov 20.

PMID:
28104256
11.

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: Afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients.

Pache F, Zimmermann H, Mikolajczak J, Schumacher S, Lacheta A, Oertel FC, Bellmann-Strobl J, Jarius S, Wildemann B, Reindl M, Waldman A, Soelberg K, Asgari N, Ringelstein M, Aktas O, Gross N, Buttmann M, Ach T, Ruprecht K, Paul F, Brandt AU; in cooperation with the Neuromyelitis Optica Study Group (NEMOS).

J Neuroinflammation. 2016 Nov 1;13(1):282.

Supplemental Content

Loading ...
Support Center